查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1786465

全球药物释放型球囊导管市场

Drug-Eluting Balloon Catheters
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 279 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球药物释放型球囊导管市场规模将达到 9.359 亿美元

全球药物释放型球囊导管市场规模预计在2024年达到6.188亿美元，预计2024年至2030年期间的复合年增长率为7.1%，到2030年将达到9.359亿美元。聚氨酯是本报告分析的细分市场之一，预计其复合年增长率为6.1%，到分析期结束时规模将达到5.327亿美元。尼龙细分市场在分析期间的复合年增长率预计为8.1%。

美国市场规模估计为 1.686 亿美元，中国市场预计复合年增长率为 11.0%

美国药物释放型球囊导管市场规模预计2024年达到1.686亿美元。作为世界第二大经济体，中国市场规模预计在2030年达到1.943亿美元，2024年至2030年的复合年增长率为11.0%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为3.6%和6.8%。在欧洲，预计德国市场的复合年增长率为4.7%。

全球药物释放型球囊导管市场－主要趋势与驱动因素摘要

为什么血管介入治疗选用药物释放型球囊导管？

心血管疾病 (CVD) 和周边动脉疾病(PAD) 的增多显着增加了对药物释放型球囊 (DEB) 导管的需求，这是传统支架的微创且高效的替代品。这些导管将抗增殖药物（如紫杉醇或Sirolimus）直接输送到受影响的动脉，减少血管再阻塞并最大程度地减少再次手术的需要。与留下永久植入的药物释放型支架 (DES) 不同，DEB 提供一种临时但有效的治疗方案，确保血管通畅性，而不会出现晚期血栓症等长期併发症。这使得 DEB 对高出血风险患者、患有小血管疾病的患者或接受反覆干预的患者特别有益。此外，人们对微创治疗的偏好日益增长，尤其是在老年族群中，这推动了 DEB 导管在冠状动脉、週边和动静脉瘘 (AVF) 手术中的广泛应用。

哪些创新增强了药物释放型球囊导管的有效性？

无聚合物药物涂层、药物保留延长策略和靶向药物传输机制的突破正在推动 DEB 技术的改进。下一代亲水性载体、奈米药物製剂和生物可吸收材料显着增强了药物在动脉壁上的黏附性，确保了持续的治疗效果。球囊设计和导管灵活性的进步也提高了药物输送的精准度和安全性，最大限度地降低了手术风险并优化了治疗效果。此外，血管内超音波(IVUS) 和光同调断层扫瞄(OCT) 等即时成像技术正在整合到 DEB 系统中，从而提高了可视化和放置精度。随着美国食品药物管理局 (FDA) 和欧洲药品管理局 (EMA) 等监管机构核准更多针对特定适应症的 DEB，市场上评估其在糖尿病血管併发症、膝下介入和透析通路维护方面的疗效的临床试验数量激增。

监理要求和市场趋势如何推动 DEB 的采用？

越来越多的监管核准DEB 用于多种血管疾病，这加速了其在全球的推广。在欧洲，DEB 已被广泛接受为支架内血管再阻塞的一线治疗，而美国和亚太地区的监管机构正在扩大其适应症，涵盖冠状动脉、週边血管甚至神经血管应用。由于导管介入手术成本效益高且住院时间短，医院和门诊手术中心正转向导管介入手术，这进一步推动了需求。此外，政府推动价值导向型医疗保健和门诊血管成形术的倡议也大力支持 DEB 的使用。日益重视将 DEB 与生物可吸收支架结合的混合手术也是一个关键的市场趋势，这将改善长期血管癒合效果。

市场成长的主要驱动力是什么？

药物洗脱球囊导管市场的成长得益于心血管疾病和周边动脉疾病负担的增加、药物输送奈米技术的进步以及微创血管内治疗的不断普及。 DEB 应用范围不断扩展，不再局限于冠状动脉介入治疗，尤其是在糖尿病足溃疡、危急性肢体缺血和血液透析机失败的治疗中，这创造了新的市场机会。此外，医疗支出的增加、介入性心臟病学投资的增加以及向门诊血管成形术中心的转变，都在支持市场扩张。随着技术的不断进步和临床检验的不断深入，DEB 导管正在成为下一代血管护理的重要组成部分。

部分

材料（聚氨酯、尼龙、其他）；最终用途（医院和诊所、门诊手术中心、心导管室）

受访公司范例

  • Balton Sp z oo
  • Becton, Dickinson and Company
  • Biosensors International Group Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardionovum GmbH
  • Concept Medical Inc.
  • Eurocor GmbH
  • iVascular SLU
  • JIANGSU CHANGMEI MEDTECH CO., LTD

人工智慧集成

我们正在利用有效的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，其中包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP30609

Global Drug-Eluting Balloon Catheters Market to Reach US$935.9 Million by 2030

The global market for Drug-Eluting Balloon Catheters estimated at US$618.8 Million in the year 2024, is expected to reach US$935.9 Million by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Polyurethane, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$532.7 Million by the end of the analysis period. Growth in the Nylon segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$168.6 Million While China is Forecast to Grow at 11.0% CAGR

The Drug-Eluting Balloon Catheters market in the U.S. is estimated at US$168.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$194.3 Million by the year 2030 trailing a CAGR of 11.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global "Drug-Eluting Balloon Catheters" Market - Key Trends & Drivers Summarized

Why Are Drug-Eluting Balloon Catheters a Preferred Choice for Vascular Interventions?

The rise in cardiovascular diseases (CVDs) and peripheral artery diseases (PADs) has significantly increased the demand for drug-eluting balloon (DEB) catheters, which offer a less invasive and highly effective alternative to traditional stents. These catheters deliver antiproliferative drugs, such as paclitaxel and sirolimus, directly to the affected arteries, reducing restenosis and minimizing the need for repeat procedures. Unlike drug-eluting stents (DES), which leave behind a permanent implant, DEBs provide a transient yet effective therapeutic solution, ensuring vessel patency without long-term complications like late thrombosis. This makes them particularly beneficial for patients with high risks of bleeding, small vessel disease, or those undergoing repeat interventions. Additionally, the growing preference for minimally invasive procedures, especially among aging populations, has driven the increased adoption of DEB catheters in coronary, peripheral, and arteriovenous fistula (AVF) treatments.

What Innovations Are Enhancing the Effectiveness of Drug-Eluting Balloon Catheters?

Breakthroughs in polymer-free drug coatings, prolonged drug retention strategies, and targeted drug delivery mechanisms are driving improvements in DEB technology. Next-generation hydrophilic carriers, nano-based drug formulations, and bioabsorbable materials have significantly enhanced drug adhesion to arterial walls, ensuring sustained therapeutic effects. Advancements in balloon design and catheter flexibility have also improved the precision and safety of drug delivery, minimizing procedural risks and optimizing outcomes. Furthermore, real-time imaging technologies, including intravascular ultrasound (IVUS) and optical coherence tomography (OCT), are now being integrated into DEB systems, allowing for enhanced visualization and placement accuracy. As regulatory bodies such as the FDA and European Medicines Agency (EMA) approve more indication-specific DEBs, the market is witnessing a surge in clinical trials evaluating their efficacy in diabetic vascular complications, below-the-knee interventions, and dialysis access maintenance.

How Are Regulatory Mandates and Market Trends Driving Adoption?

The increasing regulatory approvals for DEBs across multiple vascular indications have accelerated their global adoption. In Europe, drug-eluting balloon catheters have already gained widespread acceptance as a first-line treatment for in-stent restenosis, while regulatory agencies in the U.S. and Asia-Pacific are expanding approvals for coronary, peripheral, and even neurovascular applications. Hospitals and ambulatory surgical centers are shifting towards catheter-based interventions due to their cost-effectiveness and shorter hospital stays, further fueling demand. Additionally, government initiatives promoting value-based healthcare and outpatient angioplasty procedures have provided a strong push toward DEB utilization. The growing emphasis on hybrid procedures that combine DEBs with bioresorbable scaffolds is also a key market trend, offering better long-term vascular healing outcomes.

What Are the Primary Market Growth Drivers?

The growth in the Drug-Eluting Balloon Catheter market is driven by the increasing burden of cardiovascular and peripheral artery diseases, advancements in drug delivery nanotechnology, and the rising adoption of minimally invasive endovascular procedures. The expansion of DEB applications beyond coronary interventions, particularly in treating diabetic foot ulcers, critical limb ischemia, and hemodialysis access failures, has created new market opportunities. Additionally, rising healthcare expenditures, increasing investments in interventional cardiology, and the shift toward outpatient angioplasty centers are supporting market expansion. With ongoing technological advancements and continuous clinical validation, DEB catheters are poised to become an indispensable component of next-generation vascular care.

SCOPE OF STUDY:

The report analyzes the Drug-Eluting Balloon Catheters market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Material (Polyurethane, Nylon, Others); End-Use (Hospitals & Clinics, Ambulatory Surgery Centers, Catheterization Laboratories)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Balton Sp z o.o.
  • Becton, Dickinson and Company
  • Biosensors International Group Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardionovum GmbH
  • Concept Medical Inc.
  • Eurocor GmbH
  • iVascular S.L.U
  • JIANGSU CHANGMEI MEDTECH CO., LTD

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Drug-Eluting Balloon Catheters - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Peripheral Artery Disease Spurs Demand for Drug-Eluting Balloon Catheters
    • Aging Population and Prevalence of Chronic Cardiovascular Conditions Strengthen Business Case for Drug-Eluting Therapies
    • Increasing Preference for Minimally Invasive Procedures Accelerates Adoption of Drug-Eluting Balloon Catheters
    • Clinical Success and Favorable Outcomes Propel Growth of Drug-Eluting Balloon Technologies
    • Shorter Recovery Times and Reduced Restenosis Risk Drive Demand in Outpatient and Day-Care Surgical Settings
    • Technological Innovations in Drug Coating and Delivery Systems Expand Addressable Market Opportunity
    • Surge in Endovascular Interventions Across Emerging Economies Throws the Spotlight on Drug-Eluting Balloons
    • Shift from Traditional Angioplasty to Drug-Eluting Devices Fuels Market Transformation
    • Integration of Biodegradable Materials in Balloon Catheters Drives Innovation-Led Growth
    • Favorable Reimbursement Policies in Developed Markets Sustain Growth Momentum
    • Expanding Pipeline of Clinical Trials and Regulatory Approvals Unlocks New Market Avenues
    • Expansion of Ambulatory Surgical Centers Across Urban and Semi-Urban Regions Generates New Demand Nodes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Drug-Eluting Balloon Catheters Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Drug-Eluting Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Drug-Eluting Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Polyurethane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Polyurethane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Polyurethane by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Nylon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Nylon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Nylon by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Catheterization Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Catheterization Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Catheterization Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • JAPAN
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • CHINA
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • EUROPE
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Drug-Eluting Balloon Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Drug-Eluting Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • FRANCE
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • GERMANY
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Drug-Eluting Balloon Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Drug-Eluting Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • INDIA
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Drug-Eluting Balloon Catheters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Drug-Eluting Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Drug-Eluting Balloon Catheters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Drug-Eluting Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • AFRICA
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030

IV. COMPETITION